Van Heek joins BioVex board
October 25, 2007 08:50 AM
E-mail|
|Comments
()|
Text size
–
+
BioVex Inc.announced today that it has appointed Genzyme Corp. executive Jan van Heek as chairman of its board.
A privately held biotechnology company based in Woburn, BioVex focuses on developing a new class of biologics for the treatment of cancer and disease.
At Genzyme, a Cambridge biotechnology company, van Heek is employed as a senior advisor to the chief executive.
(By Chris Reidy, Globe staff)
Comment
Permalink
E-mail
